During the past decade, CalNeuro Research Group conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CalNeuro Research Group" are "Obsessive-Compulsive Disorder" (2 trials), "Borderline Personality Disorder" (1 trials), "Depressive Disorder, Major" (1 trials), "Depressive Disorder, Treatment-Resistant" (1 trials) and "Generalized Anxiety Disorder" (1 trials). Many other conditions were trialed in "CalNeuro Research Group" in a lesser frequency.

Most popular intervention types in "CalNeuro Research Group" are "Drug" (7 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Troriluzole" (2 trials), "Abilify MyCite®" (1 trials), "BHV-4157" (1 trials) and "Brexpiprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "CalNeuro Research Group" are 10 trials for "All" genders.

Currently, there are NaN active trials in "CalNeuro Research Group". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in CalNeuro Research Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CalNeuro Research Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".